Cel Sci CVM
NYSE CVM
$1.56 +0.01 (+0.65%)
As of: Oct 21, 2026 · 12:56 PM EDT

Cel Sci (CVM) Revenue (2010 - 2026)

Updated

Cel Sci's Revenue was $17,389 in fiscal Q3 2017 (quarter ended Jun 30, 2017), down 86.6% from $129,975 a year earlier.

Analysis

Cel Sci (CVM) Revenue (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cel Sci's Revenue was $255,667 through Jun 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn 16.99 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 15.03 Bn
10 Cel Sci 2.81 Mn -22.84 Mn - -110,240.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -110,240.00
Mar 31, 2026 -117,485.00
Dec 31, 2025 -87,789.00
Sep 30, 2025 -128,505.00
Jun 30, 2025 -172,050.00
Mar 31, 2025 -178,286.00
Dec 31, 2024 -170,103.00
Sep 30, 2024 -174,571.00
Jun 30, 2024 -190,705.00
Mar 31, 2024 -182,701.00
Dec 31, 2023 -197,696.00
Jun 30, 2023 -181,670.00
Mar 31, 2023 159,063.00
Dec 31, 2022 -152,789.00
Sep 30, 2022 379,021.00
Jun 30, 2022 -913,193.00
Mar 31, 2022 -273,828.00
Dec 31, 2021 -273,034.00
Sep 30, 2021 -276,831.00
Jun 30, 2021 -351,332.00
API Access

Cel Sci Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CVM&period=max&api_key=YOUR_API_KEY